PUMA BIOTECHNOLOGY, INC. (PBYI)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $46k
- Sep 14 · Routine
- Form 4 sales
- 250
- On record
- Form 144 notices
- 18
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleRoutineJun 12 2026
Sold 27,000 shares at $7.20 ($194k)
Senderowicz Adrian, Director
10b5-1 planSold 50% of holdings ($389k position)27,000 shares leftFiling
- 2 Form 4 saleRoutineJun 12 same day
Sold 8,100 shares at $7.20 ($58k)
Stuglik Brian M, Director
10b5-1 planSold 6.6% of holdings ($878k position)113,858 shares leftFiling
- 3 Form 4 saleRoutineJun 12 same day
Sold 10,800 shares at $7.20 ($78k)
Wilson Troy Edward, Director
10b5-1 planSold 15.3% of holdings ($508k position)59,750 shares leftFiling
- 4 Form 4 saleRoutineJul 6 +24 days
Sold 9,386 shares at $8.26 ($78k)
Nougues Maximo F, Chief Financial Officer
10b5-1 planSold 3.9% of holdings ($2M position)230,637 shares left1x usual sizeFiling
- 5 Form 4 saleRoutineJul 6 same day
Sold 8,460 shares at $8.26 ($70k)
Hunt Douglas M, Officer
10b5-1 planSold 4.1% of holdings ($1.7M position)196,841 shares left1x usual sizeFiling
- 6 Form 4 saleRoutineJul 6 same day
Sold 44,058 shares at $8.26 ($364k)
Auerbach Alan H, President and CEO
10b5-1 planSold 0.6% of holdings ($60.3M position)7.3M shares left1.3x usual sizeFiling
- 7 Form 4 saleRoutineSep 14 +70 days
Sold 62,150 shares at $9.12 ($567k)
Cesano Alessandra, Director
10b5-1 planSold 52.3% of holdings ($1.1M position)56,700 shares leftFiling
- 8 Form 4 saleRoutineSep 14 same day
Sold 5,000 shares at $9.10 ($46k)
Wilson Troy Edward, Director
10b5-1 planSold 8.4% of holdings ($544k position)54,750 shares leftFiling
Every transaction
Loading transactions…
Sales, notices and lockups (268)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Wilson Troy Edward | Director | Form 4 sale | 5,000 | $46k | 8.4% | Routine | SEC |
| Sep 14, 2026 | Cesano Alessandra | Director | Form 4 sale | 62,150 | $567k | 52.3% | Routine | SEC |
| Jul 6, 2026 | Auerbach Alan H | President and CEO | Form 4 sale | 44,058 | $364k | 0.6% | Routine | SEC |
| Jul 6, 2026 | Hunt Douglas M | Officer | Form 4 sale | 8,460 | $70k | 4.1% | Routine | SEC |
| Jul 6, 2026 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 9,386 | $78k | 3.9% | Routine | SEC |
| Jun 12, 2026 | Wilson Troy Edward | Director | Form 4 sale | 10,800 | $78k | 15.3% | Routine | SEC |
| Jun 12, 2026 | Stuglik Brian M | Director | Form 4 sale | 8,100 | $58k | 6.6% | Routine | SEC |
| Jun 12, 2026 | Senderowicz Adrian | Director | Form 4 sale | 27,000 | $194k | 50.0% | Routine | SEC |
| Jun 12, 2026 | Moyes Jay M | Director | Form 4 sale | 22,000 | $159k | 27.4% | Routine | SEC |
| Jun 12, 2026 | Dorval Allison | Director | Form 4 sale | 11,610 | $84k | 11.3% | Routine | SEC |
| Jan 7, 2026 | Auerbach Alan H | President and CEO | Form 4 sale | 34,950 | $205k | 0.5% | Routine | SEC |
| Jan 7, 2026 | Hunt Douglas M | Officer | Form 4 sale | 8,987 | $53k | 5.5% | Routine | SEC |
| Jan 7, 2026 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 10,945 | $64k | 5.4% | Routine | SEC |
| Nov 11, 2025 | Miller Michael Patrick | Director | Form 4 sale | 20,000 | $97k | 27.0% | Unusual | SEC |
| Jul 18, 2025 | Cesano Alessandra | Director | Form 4 sale | 27,000 | $91k | 39.2% | Routine | SEC |
| Jul 9, 2025 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 9,522 | $34k | 4.5% | Routine | SEC |
| Jul 9, 2025 | Hunt Douglas M | Officer | Form 4 sale | 7,817 | $28k | 4.5% | Routine | SEC |
| Jul 9, 2025 | Auerbach Alan H | President and CEO | Form 4 sale | 47,172 | $167k | 0.7% | Routine | SEC |
| Jun 13, 2025 | Wilson Troy Edward | Director | Form 4 sale | 10,800 | $37k | 19.9% | Routine | SEC |
| Jun 13, 2025 | Stuglik Brian M | Director | Form 4 sale | 8,100 | $27k | 7.9% | Routine | SEC |
| Jun 13, 2025 | Senderowicz Adrian | Director | Form 4 sale | 27,000 | $92k | 50.0% | Routine | SEC |
| Jun 13, 2025 | Moyes Jay M | Director | Form 4 sale | 22,000 | $75k | 29.2% | Routine | SEC |
| Jun 13, 2025 | Dorval Allison | Director | Form 4 sale | 11,610 | $39k | 13.3% | Routine | SEC |
| Jun 13, 2025 | Cesano Alessandra | Director | Form 4 sale | 12,150 | $41k | 15.0% | Routine | SEC |
| Jan 2, 2025 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 10,227 | $32k | 6.3% | Routine | SEC |
| Jan 2, 2025 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 9,437 | $30k | 8.0% | Routine | SEC |
| Jan 2, 2025 | Hunt Douglas M | Officer | Form 4 sale | 8,633 | $27k | 6.5% | Routine | SEC |
| Jan 2, 2025 | Auerbach Alan H | President and CEO | Form 4 sale | 33,841 | $107k | 0.5% | Routine | SEC |
| Aug 12, 2024 | Miller Michael Patrick | Director | Form 4 sale | 23,358 | $82k | 33.2% | Unusual | SEC |
| Jul 17, 2024 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 4,156 | $15k | 2.5% | Unusual | SEC |
| Jul 17, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 2,598 | $10k | 2.1% | Routine | SEC |
| Jul 17, 2024 | Hunt Douglas M | Officer | Form 4 sale | 3,637 | $13k | 2.7% | Unusual | SEC |
| Jul 17, 2024 | Auerbach Alan H | President and CEO | Form 4 sale | 21,920 | $81k | 0.3% | Unusual | SEC |
| Jul 2, 2024 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 5,295 | $17k | 3.1% | Unusual | SEC |
| Jul 2, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 6,051 | $20k | 4.8% | Routine | SEC |
| Jul 2, 2024 | Hunt Douglas M | Officer | Form 4 sale | 4,349 | $14k | 3.1% | Unusual | SEC |
| Jul 2, 2024 | Auerbach Alan H | President and CEO | Form 4 sale | 18,885 | $62k | 0.3% | Unusual | SEC |
| Jun 13, 2024 | Wilson Troy Edward | Director | Form 4 sale | 27,000 | $90k | 98.7% | Routine | SEC |
| Jun 13, 2024 | Stuglik Brian M | Director | Form 4 sale | 9,900 | $34k | 16.8% | Routine | SEC |
| Jun 13, 2024 | Senderowicz Adrian | Director | Form 4 sale | 27,000 | $90k | 100.0% | Routine | SEC |
| Jun 13, 2024 | Moyes Jay M | Director | Form 4 sale | 22,000 | $73k | 50.8% | Routine | SEC |
| Jun 13, 2024 | Dorval Allison | Director | Form 4 sale | 11,000 | $37k | 25.0% | Routine | SEC |
| Jan 3, 2024 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 7,733 | $35k | 7.3% | Unusual | SEC |
| Jan 3, 2024 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 12,956 | $58k | 11.5% | Routine | SEC |
| Jan 3, 2024 | Auerbach Alan H | President and CEO | Form 4 sale | 41,396 | $186k | 0.6% | Unusual | SEC |
| Jan 3, 2024 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 15,682 | $70k | 10.9% | Unusual | SEC |
| Jan 3, 2024 | Hunt Douglas M | Officer | Form 4 sale | 8,358 | $38k | 7.5% | Unusual | SEC |
| Jan 3, 2024 | Nougues Maximo F | Officer | Form 144 notice | 15,682 | $71k | Notice | SEC | |
| Jan 3, 2024 | Ludwig Jeffrey Jerome | Officer | Form 144 notice | 12,956 | $59k | Notice | SEC | |
| Jan 3, 2024 | Wong Alvin F | Officer | Form 144 notice | 7,733 | $35k | Notice | SEC | |
| Jan 3, 2024 | Hunt Douglas M | Officer | Form 144 notice | 8,358 | $38k | Notice | SEC | |
| Jan 3, 2024 | Auerbach Alan H | Officer, Director | Form 144 notice | 41,396 | $187k | Notice | SEC | |
| Dec 4, 2023 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 280 | $1k | 0.3% | Routine | SEC |
| Nov 7, 2023 | Miller Michael Patrick | Director | Form 4 sale | 25,000 | $71k | 36.6% | Unusual | SEC |
| Nov 7, 2023 | Miller Michael Patrick | Director | Form 144 notice | 25,000 | $70k | Notice | SEC | |
| Jul 3, 2023 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 6,938 | $23k | 6.1% | Unusual | SEC |
| Jul 3, 2023 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 14,680 | $49k | 9.2% | Unusual | SEC |
| Jul 3, 2023 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 12,103 | $40k | 9.7% | Routine | SEC |
| Jul 3, 2023 | Hunt Douglas M | Officer | Form 4 sale | 7,809 | $26k | 6.5% | Unusual | SEC |
| Jul 3, 2023 | Auerbach Alan H | President and CEO | Form 4 sale | 60,698 | $201k | 0.9% | Unusual | SEC |
| Jul 3, 2023 | Wong Alvin F | Officer | Form 144 notice | 6,938 | $24k | Notice | SEC | |
| Jul 3, 2023 | Nougues Maximo F | Officer | Form 144 notice | 14,680 | $52k | Notice | SEC | |
| Jul 3, 2023 | Ludwig Jeffrey Jerome | Officer | Form 144 notice | 12,103 | $43k | Notice | SEC | |
| Jul 3, 2023 | Hunt Douglas M | Officer | Form 144 notice | 7,809 | $28k | Notice | SEC | |
| Jul 3, 2023 | Auerbach Alan H | Officer, Director | Form 144 notice | 60,698 | $214k | Notice | SEC | |
| Jun 13, 2023 | Wilson Troy Edward | Director | Form 4 sale | 27,000 | $93k | 98.7% | Routine | SEC |
| Jun 13, 2023 | Moyes Jay M | Director | Form 4 sale | 22,000 | $76k | 57.4% | Routine | SEC |
| Jun 13, 2023 | Stuglik Brian M | Director | Form 4 sale | 9,900 | $34k | 23.7% | Routine | SEC |
| Jun 13, 2023 | Senderowicz Adrian | Director | Form 4 sale | 27,000 | $93k | 100.0% | Routine | SEC |
| Jun 13, 2023 | Dorval Allison | Director | Form 4 sale | 10,000 | $35k | 37.0% | Routine | SEC |
| Jun 13, 2023 | Miller Michael Patrick | Director | Form 4 sale | 13,500 | $47k | 24.6% | Routine | SEC |
| Jun 13, 2023 | Wilson Troy Edward | Director | Form 144 notice | 27,000 | $93k | Notice | SEC | |
| Jun 13, 2023 | Stuglik Brian M | Director | Form 144 notice | 9,900 | $34k | Notice | SEC | |
| Jun 13, 2023 | Senderowicz Adrian | Director | Form 144 notice | 27,000 | $93k | Notice | SEC | |
| Jun 13, 2023 | Moyes Jay M | Director | Form 144 notice | 22,000 | $76k | Notice | SEC | |
| Jun 13, 2023 | Miller Michael Patrick | Director | Form 144 notice | 13,500 | $47k | Notice | SEC | |
| Jun 13, 2023 | Dorval Allison | Director | Form 144 notice | 10,000 | $35k | Notice | SEC | |
| Jun 2, 2023 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 269 | $928 | 0.2% | Routine | SEC |
| Jun 2, 2023 | Wong Alvin F | Officer | Form 144 notice | 269 | $925 | Notice | SEC | |
| Jan 3, 2023 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 3,460 | $14k | 6.0% | Unusual | SEC |
| Jan 3, 2023 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 10,499 | $44k | 9.5% | Unusual | SEC |
| Jan 3, 2023 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 6,568 | $27k | 10.2% | Plan not stated | SEC |
| Jan 3, 2023 | Hunt Douglas M | Officer | Form 4 sale | 4,225 | $18k | 5.6% | Unusual | SEC |
| Jan 3, 2023 | Auerbach Alan H | President and CEO | Form 4 sale | 27,241 | $114k | 0.4% | Unusual | SEC |
| Dec 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,251 | $6k | 0.0% | Plan not stated | SEC |
| Dec 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 429 | $2k | 0.6% | Plan not stated | SEC |
| Dec 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 159 | $716 | 0.1% | Plan not stated | SEC |
| Dec 2, 2022 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 514 | $2k | 0.9% | Plan not stated | SEC |
| Nov 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 429 | $965 | 0.6% | Plan not stated | SEC |
| Nov 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,242 | $3k | 0.0% | Plan not stated | SEC |
| Nov 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 163 | $367 | 0.1% | Plan not stated | SEC |
| Oct 3, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 165 | $386 | 0.1% | Plan not stated | SEC |
| Oct 3, 2022 | Hunt Douglas M | Officer | Form 4 sale | 435 | $1k | 0.6% | Plan not stated | SEC |
| Oct 3, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,260 | $3k | 0.0% | Plan not stated | SEC |
| Sep 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 164 | $425 | 0.1% | Plan not stated | SEC |
| Sep 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 433 | $1k | 0.6% | Plan not stated | SEC |
| Sep 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,254 | $3k | 0.0% | Plan not stated | SEC |
| Aug 9, 2022 | Miller Michael Patrick | Director | Form 4 sale | 25,000 | $89k | 31.3% | Unusual | SEC |
| Aug 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 161 | $465 | 0.1% | Plan not stated | SEC |
| Aug 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 429 | $1k | 0.6% | Plan not stated | SEC |
| Aug 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,247 | $4k | 0.0% | Plan not stated | SEC |
| Jul 5, 2022 | Hunt Douglas M | Officer | Form 4 sale | 3,753 | $10k | 4.6% | Unusual | SEC |
| Jul 5, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 26,140 | $69k | 0.4% | Unusual | SEC |
| Jul 5, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 5,835 | $15k | 8.3% | Unusual | SEC |
| Jul 5, 2022 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 5,835 | $15k | 8.3% | Plan not stated | SEC |
| Jul 5, 2022 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 2,920 | $8k | 4.8% | Plan not stated | SEC |
| Jun 16, 2022 | Senderowicz Adrian | Director | Form 4 sale | 27,858 | $73k | 50.8% | Unusual | SEC |
| Jun 16, 2022 | Wilson Troy Edward | Director | Form 4 sale | 27,858 | $72k | 50.5% | Unusual | SEC |
| Jun 16, 2022 | Stuglik Brian M | Director | Form 4 sale | 13,000 | $35k | 23.7% | Plan not stated | SEC |
| Jun 16, 2022 | Moyes Jay M | Director | Form 4 sale | 22,858 | $60k | 37.4% | Unusual | SEC |
| Jun 2, 2022 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 587 | $1k | 0.9% | Plan not stated | SEC |
| Jun 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 162 | $311 | 0.1% | Plan not stated | SEC |
| Jun 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 417 | $809 | 0.5% | Plan not stated | SEC |
| Jun 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,200 | $2k | 0.0% | Plan not stated | SEC |
| May 3, 2022 | Hunt Douglas M | Officer | Form 4 sale | 438 | $1k | 0.5% | Plan not stated | SEC |
| May 3, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 165 | $386 | 0.1% | Plan not stated | SEC |
| May 3, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,263 | $3k | 0.0% | Plan not stated | SEC |
| Apr 4, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,198 | $4k | 0.0% | Plan not stated | SEC |
| Apr 4, 2022 | Hunt Douglas M | Officer | Form 4 sale | 413 | $1k | 0.5% | Plan not stated | SEC |
| Apr 4, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 206 | $634 | 0.2% | Plan not stated | SEC |
| Mar 16, 2022 | Miller Michael Patrick | Director | Form 4 sale | 25,653 | $72k | 32.7% | Unusual | SEC |
| Mar 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 169 | $382 | 0.3% | Plan not stated | SEC |
| Mar 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 446 | $1k | 0.7% | Plan not stated | SEC |
| Mar 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,294 | $3k | 0.0% | Plan not stated | SEC |
| Feb 2, 2022 | Hunt Douglas M | Officer | Form 4 sale | 533 | $1k | 0.9% | Plan not stated | SEC |
| Feb 2, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 199 | $494 | 0.3% | Plan not stated | SEC |
| Feb 2, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 1,316 | $3k | 0.0% | Plan not stated | SEC |
| Jan 3, 2022 | Ludwig Jeffrey Jerome | Chief Commercial Officer | Form 4 sale | 4,727 | $15k | 13.1% | Plan not stated | SEC |
| Jan 3, 2022 | Hunt Douglas M | Officer | Form 4 sale | 3,707 | $12k | 5.7% | Unusual | SEC |
| Jan 3, 2022 | Auerbach Alan H | President and CEO | Form 4 sale | 22,875 | $73k | 0.5% | Unusual | SEC |
| Jan 3, 2022 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 7,484 | $24k | 11.1% | Unusual | SEC |
| Dec 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 441 | $1k | 0.7% | Plan not stated | SEC |
| Dec 2, 2021 | Wong Alvin F | Chief Scientific Officer | Form 4 sale | 1,131 | $3k | 6.2% | Plan not stated | SEC |
| Dec 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 162 | $478 | 0.2% | Plan not stated | SEC |
| Dec 2, 2021 | Auerbach Alan H | President and CEO | Form 4 sale | 1,837 | $5k | 0.0% | Plan not stated | SEC |
| Nov 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 156 | $885 | 0.2% | Plan not stated | SEC |
| Nov 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 427 | $2k | 0.7% | Plan not stated | SEC |
| Nov 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,795 | $10k | 0.0% | Plan not stated | SEC |
| Oct 4, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 161 | $998 | 0.2% | Plan not stated | SEC |
| Oct 4, 2021 | Hunt Douglas M | Officer | Form 4 sale | 443 | $3k | 0.7% | Plan not stated | SEC |
| Oct 4, 2021 | Auerbach Alan H | President and CEO | Form 4 sale | 1,858 | $11k | 0.0% | Unusual | SEC |
| Sep 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 422 | $3k | 0.6% | Plan not stated | SEC |
| Sep 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,764 | $13k | 0.0% | Unusual | SEC |
| Sep 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 155 | $1k | 0.2% | Plan not stated | SEC |
| Aug 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 154 | $1k | 0.2% | Plan not stated | SEC |
| Aug 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 420 | $3k | 0.6% | Plan not stated | SEC |
| Aug 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,764 | $13k | 0.0% | Unusual | SEC |
| Jul 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 5,332 | $47k | 0.1% | Unusual | SEC |
| Jul 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 155 | $1k | 0.2% | Plan not stated | SEC |
| Jul 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 1,016 | $9k | 1.5% | Plan not stated | SEC |
| Jun 11, 2021 | Senderowicz Adrian | Director | Form 4 sale | 40,993 | $458k | 100.0% | Unusual | SEC |
| Jun 10, 2021 | Wilson Troy Edward | Director | Form 4 sale | 25,748 | $292k | 98.7% | Unusual | SEC |
| Jun 10, 2021 | Moyes Jay M | Director | Form 4 sale | 25,248 | $287k | 80.0% | Unusual | SEC |
| Jun 10, 2021 | Miller Ann Calby | Director | Form 4 sale | 12,874 | $147k | 50.0% | Unusual | SEC |
| Jun 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 152 | $2k | 0.2% | Plan not stated | SEC |
| Jun 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 416 | $4k | 0.6% | Plan not stated | SEC |
| Jun 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,757 | $19k | 0.0% | Unusual | SEC |
| May 3, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 152 | $2k | 0.2% | Plan not stated | SEC |
| May 3, 2021 | Hunt Douglas M | Officer | Form 4 sale | 417 | $4k | 0.6% | Plan not stated | SEC |
| May 3, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,758 | $16k | 0.0% | Unusual | SEC |
| Apr 5, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 155 | $2k | 0.2% | Plan not stated | SEC |
| Apr 5, 2021 | Hunt Douglas M | Officer | Form 4 sale | 426 | $4k | 0.6% | Plan not stated | SEC |
| Apr 5, 2021 | Bryce Richard Paul | Officer | Form 4 sale | 426 | $4k | 0.3% | Unusual | SEC |
| Apr 5, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,584 | $16k | 0.0% | Unusual | SEC |
| Mar 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 154 | $2k | 0.2% | Plan not stated | SEC |
| Mar 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 422 | $4k | 0.6% | Plan not stated | SEC |
| Mar 2, 2021 | Bryce Richard Paul | Officer | Form 4 sale | 422 | $4k | 0.3% | Unusual | SEC |
| Mar 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,238 | $13k | 0.0% | Plan not stated | SEC |
| Feb 2, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 179 | $2k | 1.3% | Plan not stated | SEC |
| Feb 2, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 1,222 | $15k | 0.0% | Plan not stated | SEC |
| Feb 2, 2021 | Bryce Richard Paul | Officer | Form 4 sale | 415 | $5k | 0.6% | Unusual | SEC |
| Feb 2, 2021 | Hunt Douglas M | Officer | Form 4 sale | 412 | $5k | 0.8% | Plan not stated | SEC |
| Jan 4, 2021 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 18,235 | $186k | 0.4% | Unusual | SEC |
| Jan 4, 2021 | Nougues Maximo F | Chief Financial Officer | Form 4 sale | 2,145 | $22k | 13.8% | Plan not stated | SEC |
| Jan 4, 2021 | Hunt Douglas M | Officer | Form 4 sale | 6,463 | $66k | 11.4% | Unusual | SEC |
| Jan 4, 2021 | Bryce Richard Paul | Officer | Form 4 sale | 6,548 | $67k | 8.5% | Unusual | SEC |
| Dec 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 92 | $1k | 0.1% | Plan not stated | SEC |
| Dec 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 355 | $4k | 0.0% | Plan not stated | SEC |
| Nov 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 97 | $758 | 0.1% | Plan not stated | SEC |
| Nov 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 371 | $3k | 0.0% | Plan not stated | SEC |
| Oct 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 350 | $4k | 0.0% | Plan not stated | SEC |
| Oct 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 91 | $923 | 0.1% | Plan not stated | SEC |
| Sep 16, 2020 | Moyes Jay M | Director | Form 4 sale | 9,703 | $97k | 23.5% | Plan not stated | SEC |
| Sep 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 90 | $879 | 0.1% | Plan not stated | SEC |
| Sep 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 347 | $3k | 0.0% | Plan not stated | SEC |
| Aug 3, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 86 | $929 | 0.1% | Plan not stated | SEC |
| Aug 3, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 330 | $4k | 0.0% | Plan not stated | SEC |
| Jul 2, 2020 | Hunt Douglas M | Officer | Form 4 sale | 572 | $6k | 1.0% | Plan not stated | SEC |
| Jul 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 660 | $7k | 0.8% | Unusual | SEC |
| Jul 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 2,607 | $28k | 0.1% | Unusual | SEC |
| Jun 16, 2020 | Moyes Jay M | Director | Form 4 sale | 9,720 | $92k | 19.1% | Plan not stated | SEC |
| Jun 11, 2020 | Wilson Troy Edward | Director | Form 4 sale | 25,245 | $252k | 49.2% | Unusual | SEC |
| Jun 11, 2020 | Senderowicz Adrian | Director | Form 4 sale | 10,000 | $99k | 19.6% | Plan not stated | SEC |
| Jun 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 342 | $4k | 0.0% | Plan not stated | SEC |
| Jun 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 89 | $949 | 0.1% | Plan not stated | SEC |
| May 4, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 89 | $856 | 0.1% | Plan not stated | SEC |
| May 4, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 339 | $3k | 0.0% | Plan not stated | SEC |
| Apr 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 91 | $671 | 0.1% | Plan not stated | SEC |
| Apr 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 347 | $3k | 0.0% | Plan not stated | SEC |
| Mar 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 96 | $962 | 0.1% | Plan not stated | SEC |
| Mar 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 372 | $4k | 0.0% | Plan not stated | SEC |
| Feb 27, 2020 | Hunt Douglas M | Officer | Form 4 sale | 1,728 | $18k | 3.2% | Plan not stated | SEC |
| Feb 3, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 105 | $842 | 0.3% | Plan not stated | SEC |
| Feb 3, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 331 | $3k | 0.0% | Plan not stated | SEC |
| Jan 2, 2020 | Hunt Douglas M | Officer | Form 4 sale | 1,405 | $12k | 11.1% | Plan not stated | SEC |
| Jan 2, 2020 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 6,016 | $50k | 0.1% | Unusual | SEC |
| Jan 2, 2020 | Bryce Richard Paul | Officer | Form 4 sale | 1,516 | $13k | 4.2% | Unusual | SEC |
| Dec 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 83 | $858 | 0.2% | Plan not stated | SEC |
| Dec 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 455 | $5k | 0.0% | Plan not stated | SEC |
| Nov 4, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 88 | $649 | 0.2% | Plan not stated | SEC |
| Nov 4, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 478 | $4k | 0.0% | Plan not stated | SEC |
| Oct 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 91 | $915 | 0.2% | Plan not stated | SEC |
| Oct 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 504 | $5k | 0.0% | Plan not stated | SEC |
| Sep 12, 2019 | Hunt Douglas M | Officer | Form 4 sale | 1,711 | $20k | 11.9% | Plan not stated | SEC |
| Sep 4, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 524 | $5k | 0.0% | Plan not stated | SEC |
| Sep 4, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 95 | $960 | 0.3% | Plan not stated | SEC |
| Aug 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 517 | $5k | 0.0% | Plan not stated | SEC |
| Aug 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 94 | $846 | 0.3% | Plan not stated | SEC |
| Jul 22, 2019 | Lo Steven | Chief Commercial Officer | Form 4 sale | 1,852 | $19k | 8.7% | Plan not stated | SEC |
| Jul 22, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 1,841 | $19k | 4.8% | Plan not stated | SEC |
| Jul 22, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 12,715 | $127k | 0.3% | Unusual | SEC |
| Jul 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 495 | $6k | 0.0% | Plan not stated | SEC |
| Jul 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 89 | $1k | 0.2% | Plan not stated | SEC |
| Jun 3, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 88 | $1k | 0.2% | Plan not stated | SEC |
| Jun 3, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 483 | $7k | 0.0% | Plan not stated | SEC |
| May 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 85 | $3k | 0.2% | Plan not stated | SEC |
| May 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 477 | $15k | 0.0% | Plan not stated | SEC |
| Apr 2, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 88 | $3k | 0.2% | Plan not stated | SEC |
| Apr 2, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 491 | $18k | 0.0% | Plan not stated | SEC |
| Mar 4, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 88 | $3k | 0.2% | Plan not stated | SEC |
| Mar 4, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 496 | $19k | 0.0% | Plan not stated | SEC |
| Feb 4, 2019 | Eyler Charles R | Officer | Form 4 sale | 87 | $2k | 0.3% | Plan not stated | SEC |
| Feb 4, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 89 | $2k | 0.3% | Plan not stated | SEC |
| Feb 4, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 345 | $10k | 0.0% | Plan not stated | SEC |
| Jan 22, 2019 | Lo Steven | Chief Commercial Officer | Form 4 sale | 2,114 | $53k | 9.0% | Plan not stated | SEC |
| Jan 22, 2019 | Eyler Charles R | Officer | Form 4 sale | 713 | $18k | 2.2% | Plan not stated | SEC |
| Jan 22, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 1,959 | $48k | 6.3% | Plan not stated | SEC |
| Jan 22, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 8,825 | $218k | 0.2% | Plan not stated | SEC |
| Jan 3, 2019 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 4,424 | $91k | 0.1% | Plan not stated | SEC |
| Jan 3, 2019 | Eyler Charles R | Officer | Form 4 sale | 1,210 | $25k | 3.6% | Plan not stated | SEC |
| Jan 3, 2019 | Bryce Richard Paul | Officer | Form 4 sale | 1,210 | $25k | 3.7% | Plan not stated | SEC |
| Dec 3, 2018 | Eyler Charles R | Officer | Form 4 sale | 1,239 | $28k | 3.5% | Plan not stated | SEC |
| Jul 20, 2018 | Lo Steven | Chief Commercial Officer | Form 4 sale | 1,839 | $95k | 7.3% | Plan not stated | SEC |
| Jul 20, 2018 | Eyler Charles R | Officer | Form 4 sale | 610 | $32k | 1.7% | Plan not stated | SEC |
| Jul 20, 2018 | Bryce Richard Paul | Officer | Form 4 sale | 1,836 | $95k | 5.3% | Plan not stated | SEC |
| Jul 20, 2018 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 12,520 | $651k | 0.3% | Plan not stated | SEC |
| Jun 1, 2018 | Eyler Charles R | Officer | Form 4 sale | 1,211 | $64k | 3.3% | Plan not stated | SEC |
| Jan 22, 2018 | Lo Steven | Chief Commercial Officer | Form 4 sale | 1,858 | $173k | 6.8% | Plan not stated | SEC |
| Jan 22, 2018 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 1,860 | $173k | 6.8% | Plan not stated | SEC |
| Jan 22, 2018 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 10,692 | $992k | 0.3% | Plan not stated | SEC |
| Dec 1, 2017 | Eyler Charles R | Officer | Form 4 sale | 1,322 | $139k | 4.4% | Plan not stated | SEC |
| Sep 29, 2017 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 15,000 | $1.8M | 35.5% | Unusual | SEC |
| Sep 7, 2017 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 15,000 | $1.5M | 35.5% | Unusual | SEC |
| Jul 20, 2017 | Lo Steven | Chief Commercial Officer | Form 4 sale | 1,990 | $189k | 6.8% | Plan not stated | SEC |
| Jul 20, 2017 | Eyler Charles R | Officer | Form 4 sale | 662 | $63k | 2.2% | Plan not stated | SEC |
| Jul 20, 2017 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 1,998 | $189k | 6.8% | Plan not stated | SEC |
| Jul 20, 2017 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 13,175 | $1.2M | 0.3% | Plan not stated | SEC |
| Jul 3, 2017 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 5,000 | $436k | 14.6% | Plan not stated | SEC |
| Jun 12, 2017 | Adage Capital Partners Gp, L.L.C. | 10% owner | Form 4 sale | 247,260 | $19.9M | 6.3% | Plan not stated | SEC |
| Jun 5, 2017 | Adage Capital Partners, L.P. | 10% owner | Form 4 sale | 507,128 | $44.5M | 11.4% | Plan not stated | SEC |
| May 26, 2017 | Adage Capital Partners Gp, L.L.C. | 10% owner | Form 4 sale | 1.2M | $93.1M | 21.7% | Plan not stated | SEC |
| Feb 1, 2017 | Charnas Robert | Other | Form 4 sale | 3,008 | $96k | 10.2% | Plan not stated | SEC |
| Jan 20, 2017 | Lo Steven | Chief Commercial Officer | Form 4 sale | 2,290 | $76k | 7.3% | Plan not stated | SEC |
| Jan 20, 2017 | Eyler Charles R | Officer | Form 4 sale | 820 | $27k | 7.8% | Plan not stated | SEC |
| Jan 20, 2017 | Charnas Robert | Other | Form 4 sale | 2,293 | $76k | 7.2% | Plan not stated | SEC |
| Jan 20, 2017 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 2,293 | $76k | 7.3% | Plan not stated | SEC |
| Jan 20, 2017 | Auerbach Alan H | PRESIDENT AND CEO | Form 4 sale | 10,202 | $339k | 0.2% | Plan not stated | SEC |
| Jul 6, 2015 | Bryce Richard Paul | SR VP, CLINICAL RESEARCH & DEV | Form 4 sale | 3,000 | $330k | 99.0% | Unusual | SEC |